Skip to main content

Table 1 Summary of alterations of E-cadherin and β-catenin in a series of 50 gastric tumours.

From: Alterations of E-cadherin and β-catenin in gastric cancer

Tumour

Stage

Type

Grade

LOH

E-cad gene mutations

Aberrant mRNA

E-cad

β-cat

Sample

   

at 16q22.1

and polymorphisms

of E-cad

IHC

IHC

1

T3N3

diff

 

+

IVS1+6T→C

-

+/-

++/-

3

T3N1

squ

G1

+

IVS4+10C→G

ND

-

+/-

17

T3N1

diff

 

ND

GTG(Val)→GTC(Val) at cd832

ND

-

-

23

 

met

 

+

GCC(Ala)→ACC(Thr) at cd592*

ND

+++/-

+++/-

43

T3N2

diff

 

+

-

-

-

+++/-

50

T3N1

diff

 

-

IVS1+6T→C

-

++/-

++/-

165

T3N1

int

G3

ND

-

-

+++/-

+++/-

174

T3N2

int

G3

-

-

ND

+++/-

++/-

193

T3N2

int

G3

+

-

ND

-/+++

-/++

200

T3N1

int

G2

-

IVS4+10C→G

-

++/-

+++/-

231

T3N0

mi

G3

+

-

-

++/-

++/-

283

T3N0

int

G3

ND

-

ND

++/-

++/-

287

T3N1

int

G2

+

-

-

-/+

++/-

294

T3N1M1

mi

G4

+

GCC(Ala)→ACC(Thr) at cd592♦

-

++/-

++/-

304

T3N3

int

G2

-

-

-

-/+++

+/-

308

T3N1

int

G2

+

-

-

+++/-

++/-

314

T3N1

diff

 

-

CAC(His)→CAT(His) at cd632

-

+++/-

++/-

     

GGC(Gly)→GGT(Gly) at cd865

   

360

T2N1

int

G3

+

IVS4+10C→G

+♣

++/-

+/-

369

 

met

 

+

-

+♣

+++/-

++/-

433

T3N1

mi

G3

-

IVS4+10C→G

-

-/++

-/+

435

T2N0

int

G3

+

-

-

-/+++

-/++

443

T2N0

int

G4

-

-

-

+++/-

+++/-

451

T4N0

int

G2

ND

-

ND

+++/-

++/-

474

T3N1

int

G3

ND

-

ND

-

+/-

493

T3N1

int

G3

+

-

-

-/+++

+/-

503

T3N1

int

G3

ND

-

-

-

+++/-

556

T3N2

int

G2

-

IVS1+6T→C

ND

++/-

+/-

     

5'UTR-71C→G

   

568

T3N2

mi

G3

+

-

+♣

++/-

++/-

612

T3N0

int

G2

ND

IVS4+10C→G

-

+++/-

+/-

     

AAC(Asn)→AAT(Asn) at cd751

   

636

T3N1

diff

 

+

IVS4+10C→G

ND

+++/-

+++/-

650

T2N0M1

int

G2

+

-

ND

-/+

++/-

675

T2N0

mi

G3

+

IVS4+10C→G

-

+/-

++/-

676

T3N1

int

G2

+

-

-

+++/-

-

680

T3N1

mi

G3

+

IVS1+6T→C

-

++/-

++/-

     

AAC(Asn)→AAT(Asn) at cd751

   

694

T3N1

int

G1

+

-

-

+++/-

+++/-

717

T3N1

int

G3

+

-

+

-/+++

+++/-

726

T2N1

int

G2

+

IVS4+10C→G

-

-/+++

++/-

728

T3N0

int

G2

+

GCC(Ala)→ACC(Thr) at cd592

-

-/+++

++/-

729

T3N1

int

G1

-

IVS1+6T→C

-

-/+++

+++/-

732

T2N1

int

G3

+

-

-

-/+++

+++/-

735

T4N3

diff

 

ND

AAC(Asn)→AAT(Asn) at cd751

-

+++/-

+++/-

738

T3N2

diff

 

+

-

-

-

-

750

 

met

 

ND

AAC(Asn)→AAT(Asn) at cd751

+

++/-

+++/-

755

T2N1

int

G2

ND

-

+

+++/-

++/-

808

T3N0

int

G1

+

ACG(Thr)→ACA(Thr) at cd251

+

+++/-

++/-

811

T2N1

int

G2

+

-

-

+++/-

-/+

832

T3N2

int

G2

+

-

-

+++/-

+++/-

855

T3N2

int

G2

+

-

-

+++/-

+++/-

875

T3N2

int

G2

-

IVS4+10C→G

ND

+++/-

+++/-

904

T2N0

int

G3

+

IVS4+10C→G

-

-/+++

++/-

Useful

   

30

3

7

21

14

Total

   

40

50

38

50

50

%

   

75

6

18

42

28

  1. T, tumour (size and invasiveness); N, node (degree of metastasis); M, metastasis; G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; G4, not differentiated; diff, diffuse (degree of differentiation=G4); mi, mixed; int, intestine; met, metastatic tumour probably from stomach tumour; squ, squamous epithelial; LOH, loss of heterozygosity; E-cad, E-cadherin; β-cat, β-catenin; IHC, immunohistochemistry; cd, codon; UTR, untranslated region; +, positive LOH, aberrant E-cad mRNA, E-cad and β-cat IHC;-, negative LOH, E-cadherin gene mutation, aberrant E-cad mRNA, E-cad and β-cat IHC; ND, not determined or not done; +/-, ++/- and +++/-, more than 50% cells positive; -/+, -/++ and -/+++, more than 50% cells negative; *, somatic mutation; ♦, germline mutation; ♣, insertion of intron 7 between exons 7 and 8, stop codon 374; ♥, deletion of last 72 bases of exon 7, exon 8 and first 124 bases of exon 9, stop codon 322; ♠, deletion of exons 8 and 9; deletion of last 84 bases of exon 8, stop codon 358; , these samples also showed cytoplasmic staining for β-catenin IHC.